Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1131 of 1,261
  1. US 6902910

    Death domain containing receptor 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jun 7, 2005 Β· Expires Jun 2, 2025

    expired
  2. US 6902907

    Cystic fibrosis gene

    The Board of Regents Acting For and on Behalf of The University of Michigan Β· Granted Jun 7, 2005 Β· Expires Jun 2, 2025

    expired
  3. US 6902743

    Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix

    The United States of America as represented by the Secretary of the Army Β· Granted Jun 7, 2005 Β· Expires Jun 2, 2025

    expired
  4. US 6903125

    Tetrahydro-2H-thiopyran-4-carboxamide derivative

    Rational Drug Design Laboratories Β· Granted Jun 7, 2005 Β· Expires Jun 2, 2025

    expired
  5. US 6903070

    Glycopeptide carboxy-saccharide derivatives

    Theravance, Inc. Β· Granted Jun 7, 2005 Β· Expires Jun 2, 2025

    expired
  6. US 6899895

    Lamellar gels and methods for making and regulating

    The Regents of the University of California Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  7. US 6899880

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

    The Regents of the University of California Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  8. US 6899892

    Methods to reduce body fat

    Regents of the University of Minnesota Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  9. US 6899898

    Induced phase transition method for the production of microparticles containing hydrophobic active agents

    Nektar Therapeutics Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  10. US 6900024

    T cell receptor ligands and methods of using same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  11. US 6900045

    Human kinase proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  12. US 6900027

    Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

    Precision Therapeutics, Inc. Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  13. US 6900213

    Bisaryl derivatives having FSH modulatory activity

    Pharmacopeia Drug Discovery, Inc. Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  14. US 6900236

    Cannabimimetic indole derivatives

    UNIVERSITY OF CONNECTICUT Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  15. US 6899873

    Method of forming micro-tubular polymeric materials

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  16. US 6899882

    Endothelial cell growth factor methods of isolation and expression

    The Regents of the University of California Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  17. US 6899867

    Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation Β· Granted May 31, 2005 Β· Expires May 26, 2025

    expired
  18. US 6897052

    N-acetylglycosaminyl transferase genes

    GlycoDesign Holdings Ltd. Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  19. US 6897227

    Prodrugs of proton pump inhibitors

    The United States of America as represented by the Department of Veteran Affairs Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  20. US 6897016

    Alteration of sequence of a target molecule

    The Regents of the University of Colorado Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  21. US 6897305

    Calcium channel drugs and uses

    Theravance, Inc. Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  22. US 6897196

    pH sensitive lipids based on ortho ester linkers, composition and method

    The Regents of the University of California Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  23. US 6897316

    Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents

    China Medical University Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired
  24. US 6896909

    Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders

    WINMEDICAL S.R.L. Β· Granted May 24, 2005 Β· Expires May 19, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.